Article citationsMore>>

Wessels, A.M., Tariot, P.N., Zimmer, J.A., Selzler, K.J., Bragg, S.M., Andersen, S.W., Landry, J., Krull, J.H., Downing, A.M., Willis, B.A., Shcherbinin, S., Mullen, J., Barker, P., Schumi, J., Shering, C., Matthews, B.R., Stern, R.A., Vellas, B., Cohen, S., MacSweeney, E., Boada, M. and Sims, J.R. (2019) Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials. JAMA Neurology, 77, 199-209.
http://dx.doi.org/10.1001/jamaneurol.2019.3988

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top